ClinicalTrials.gg
CompletedNCT07127783Updated Nov 3, 2026

Physical Therapy After Endometriosis Excision

An interventional study of Active Recovery and Standard Postoperative Instructions in Endometriosis and Surgery, sponsored by Oregon Health and Science University. Completed at 1 site in United States. Open to female participants aged 18 Years to 50 Years. Per ClinicalTrials.gov, last updated 2026-11-03.

Sponsored by Oregon Health and Science University · Not applicable, Interventional, and Treatment

How we know

Updated Nov 3, 2026Now CompletedPrimary completion moved+2 moreGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
21
Allocation
Randomized
Ages
18 Years to 50 Years
Sex
Female
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 169 studies in Endometriosis with a site in United States — 38 open to participants now, 48 under way, 5 of them phase 3. Endometriosis · United States.

Enrollment
93rd of 131
21 · median 60
Started
2025
with 14 others
No phase
39 of 169
12 open now
Registered
157th of 169
by date

Among the 169 studies in Endometriosis with a site in United States, this one is the 93rd largest by enrollment of the 131 interventional ones that give a count, is one of 15 that started in 2025, is one of 39 with no phase, and was the 157th registered.

Endometriosis

924 studies on the registry are indexed under Endometriosis; 268 are open to participants now.

Browse Endometriosis studies →

Open to participants now

38 of the 169 studies in Endometriosis with a site in United States are open now. Recruiting first, the newest first:

33 more — sign in →

All 38 open studies →

A study can be open while its sites in United States have not opened yet or have stopped. Only those recruiting at a site in United States →

Who these studies take

Of the 180 Endometriosis studies recruiting now, 53 (29%) set no upper age limit and 125 (69%) stop at 75 or younger; 18 take children under 18; 39 take healthy volunteers.

This study: 18 Years to 50 Years · female · no healthy volunteers.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 169 studies in Endometriosis with a site in United States, or all of them as a file.
02

Study summary

This is a randomized controlled pilot study comparing a home pelvic floor physical therapy program to routine post-operative care for patients undergoing endometriosis excisional surgery without hysterectomy. Quality of life and endometriosis symptoms will be compared following the recovery period.

Read the detailed description

This is a randomized controlled pilot study conducted at a single institution comparing a home pelvic floor physical therapy program to routine post-operative care for patients undergoing endometriosis excisional surgery without hysterectomy. Patients will be recruited from a referral gynecological surgery group specializing in the diagnosis and treatment of pelvic pain and endometriosis. The goal is to assess the role of the active recovery program on quality of life and on pain and endometriosis symptoms.

Subjects will be randomized to routine post-operative care or to a home physical therapy program, in which they will receive written instruct ions and videos of exercises to complete immediately after surgery. The home exercise program was developed by the Department of Urogynecology in conjunction with pelvic floor physical therapists, and includes videos created by the education communications division. Quality of life, pain score, and endometriosis symptoms will be assessed at their pre-operative appointment, and at 6 and 12 weeks postoperatively.

03

Conditions studied

  • Endometriosis
  • Surgery

Browse trials for

Keywords

  • Active Recovery
04

Who can participate

Ages eligible
18 Years to 50 Years
Sexes eligible
Female
Accepts healthy volunteers
No

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Premenopausal
  • English speaking
  • Undergoing endometriosis excision surgery without hysterectomy at Legacy Health with subspecialty-trained surgeons specializing in endometriosis care
  • History of chronic pelvic pain (defined as >= 6 months of pain in the anatomic pelvis)
  • Diagnosis of high tone pelvic floor dysfunction on examiniation
  • Have access to reliable email and phone for study-related communication

Exclusion criteria

Exclusion Criteria:

  • Non-English speaking
  • Unable to consent
  • Unable to sustain 30 minutes of moderate activity at baseline
  • Uses a mobility assistive device at baseline
  • Chronic opioid use
  • No histologic diagnosis of endometriosis on surgical pathology
  • Need for additional pelvic rest (>2 weeks) postoperatively
  • Pregnancy or planning to pursue pregnancy or undergo fertility treatments within 12 weeks postoperatively
05

Study design

Phase
Not applicable
Primary purpose
Treatment
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
21 participants (actual)

Study arms

  • Active comparator
    Standard Postoperative Instructions

    Participants will receive standard postoperative recovery instructions

    Behavioral: Standard Postoperative Instructions

  • Experimental
    Active Recovery

    Participants will receive postoperative instructions to follow an active recovery protocol focused on increasing activity level, core strength exercises, and pelvic floor exercises focused on urinary and bowel symptoms. Exercises are to be completed twice per day for the 12 weeks following surgery.

    Behavioral: Active Recovery

Interventions

  • BehavioralActive Recovery

    Participants will receive postoperative instructions to follow an active recovery protocol focused on increasing activity level, core strength exercises, and pelvic floor exercises focused on urinary and bowel symptoms. Exercises are to be completed twice per day for the 12 weeks following surgery.

  • BehavioralStandard Postoperative Instructions

    Standard of care postoperative instructions covering incision care, pain control, dietary instructions, and emergency precautions. Also includes guidelines regarding pelvic rest and lifting restrictions.

06

What researchers measure

Primary outcomes

  1. Short Form Survey (SF-36)

    The Short Form Survey (SF-36) is a 36-item survey regarding general health and pain and its impact on quality of life including physical activities, work, social activities, and emotional well-being over the last four weeks. Scores range from 0 to 100 with a higher score representing a more favorable health state.

    Time frame: Collected immediately following surgery, 6 weeks following surgery, and 12 weeks following surgery

  2. Pelvic Floor Impact Questionnaire (PFIQ)

    The Pelvic Floor Impact Questionnaire (PFIQ) asks about how bladder, bowel, and pelvic symptoms affect the ability to do physical activities as well as their impact on emotional well-being over the last 3 months. Scores range from 0 to 300 with a lower score representing a lesser impact on quality of life.

    Time frame: Collected immediately following surgery and 12 weeks following surgery

Secondary outcomes

  1. Pain Scores

    Pain measured using a Visual Analog Scale (VAS). This scale asks patients to rate their pelvic pain and dyspareunia over the last 4 weeks. Responses are on a scale from 0 to 10, with 10 being the worst pain.

    Time frame: Collected at baseline, 6 weeks following surgery, and 12 weeks following surgery.

  2. Endometriosis Health Profile (EHP-5)

    The Endometriosis Health Profile (EHP-5) is a 5-item questionnaire asking about the perception of endometriosis symptoms on physical ability, emotional well-being, mood, social isolation, and appearance over the last four weeks. Scores range from 0 to 100 where 0 indicates the best health status.

    Time frame: Collected at baseline, 6 weeks following surgery, and 12 weeks following surgery.

07

Study locations

1 site
  • Oregon Health & Science University
    Portland, Oregon 97239, United States
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedDate before it movedWhere the date was before it movedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Ran from Aug 2025 to primary completion in May 2026, 8 months.

Of 199 non-industry interventional studies with no phase under Endometriosis, half reached primary completion within 24 months of starting (the median), counting those still running; a quarter within 13 and three quarters within 44. This study's 8 months is below that.

Counting every sponsor, half of 214 studies reached it within 25 months; a quarter within 13 and three quarters within 44.

Since we started tracking on Sep 25, 2026, the dates moved once, on Nov 3, 2026: primary completion Mar 2026 → May 2026 and completion Mar 2026 → May 2026.

Earlier changes are on the record history on ClinicalTrials.gov ↗

How these figures are worked out, and which studies are left out of them.

Registered
Aug 11, 2025
First posted
Aug 17, 2025
StartActual
Aug 28, 2025
Primary completionActual
May 12, 2026was Mar 2026
CompletionActual
May 12, 2026was Mar 2026
Last update
Nov 3, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Status
Recruiting→Completed
changed Nov 3, 2026
Primary completion
Mar 2026→May 12, 2026 (actual)
Nov 3, 2026
Study completion
Mar 2026→May 12, 2026 (actual)
Nov 3, 2026
Enrollment
30 (estimated)→21 (actual)
Nov 3, 2026
Show all 1 update
  1. Nov 3, 2026
    Recruiting→Completed
    Primary completion Mar 2026→May 12, 2026 (now actual)
    Study completion Mar 2026→May 12, 2026 (now actual)
    Enrollment 30 (estimated)→21 (actual)
    + 4 other changes: verification date, oversight details, contact details and site details

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07127783
Responsible party
Jacqueline Wong (Principal Investigator, Oregon Health and Science University) — Principal investigator
First posted
Aug 17, 2025
Start date
Aug 28, 2025
Primary completion
May 12, 2026
Completion
May 12, 2026
Last update
Nov 3, 2026

Study contacts

Jacqueline Wong
principal investigator · Oregon Health and Science University

Oversight

FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Not currently enrolling

This study is completed, as verified in Oct 2026. You cannot join it, but the record below documents what was studied.

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion